Plasma Levels of Insulin-Like Growth Factor-I Are Reduced at One Week of Age in Monosodium L-Glutamate-Treated Mice

Endocrine Journal

Volumn 40, Issue 4, 1993, Pages 461-465

  Yamamoto, Toru ^a   Matsuo, Satoshi ^a   Ueshima, Yasuo ^a   Inoue, Fumio ^a   Kinugasa, Akihiko ^a   Sawada, Tadashi ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

IGF I; MSG treated mice

Indexed keywords

GLUTAMATE SODIUM; INSULIN; SOMATOMEDIN C; THYROXINE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; MOUSE; NONHUMAN; PANCREAS; PRIORITY JOURNAL;

AGE FACTORS; ANIMAL; ANIMALS, NEWBORN; GROWTH DISORDERS; HYPOTHALAMUS; INSULIN; INSULIN-LIKE GROWTH FACTOR I; MALE; MICE; MICE, INBRED ICR; OBESITY; SODIUM GLUTAMATE; THYROXINE;

EID: 0027379086     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.40.461     Document Type: Article

References (21)

1. Olney JW (1969) Brain lesions, obesity, and other disturbances in mice treated with monosodium glutamate. Science 164: 719-721.
2. Tanaka K, Shimada M, Nakao K, Kusunoki T (1978) Hypothalamic lesion induced by injection of monosodium glutamate in suckling period and subsequent development of obesity. Exp Neurol 62: 191-199.
3. Hashigami Y (1989) Effects of neonatal administration of monosodium glutamate on four neuropeptide concentrations in the rat brain. Folia Endocrinol Japon 65: 79-90 (In Japanese).
4. Bernardis LL, Patterson BD (1968) Correlation between ‘Lee index’ and carcase fat content in weanling and adult female rats with hypothalamic lesions. J Endocr 40: 527-528.
5. Suwa S, Katsumata N, Maesaka H, Tokuhiro E, Yokoya S (1988) Serum insulin-like growth factor I (somatomedid-C) level in normal subjects from infancy to adulthood, pituitary dwarfs and normal variant short stature. Endocrinol Japon 35: 857-864.
6. Maiter D, Underwood LE, Martin JB, Koenig JI (1991) Neonatal treatment with monosodium glutamate: Effects of prolonged growth hormone (GH)-releasing hormone deficiency on pulsatile GH secretion and growth in female rats. Endocrinology 128: 1100-1106.
7. Bakke JL, Lawrence N, Bennett J, Robinson S, Bowers CY (1978) Late endocrine effects of administering monosodium glutamate to neonatal rats. Neuroendocrinology 26: 220-228.
8. Terry LS, Epelbaum J, Martin JB (1981) Monosodium glutamate: Acute and chronic effects on rhythmic growth hormone and prolactin secretion, and somatostatin in undisturbed male rat. Brain Research 217: 129-142.
9. Millard WJ, Martin JB, Audet J, Sagar SM, Martin JB (1982) Evidence that reduced growth hormone secretion observed in monosodium glutamate-treated rats is the result of a deficiency in growth hormone-releasing factor. Endocrinology 110: 540-550.
10. Nemeroff CB, Konkol RJ, Bissette G, Youngblood W, Martin JB, Brazeau P, Rone MS, Prange AJ, Breese GR, Kizer JS (1977) Analysis of the disruption in hypothalamic-pituitary regulation in rats treated neonatally with monosodium L-glutamate (MSG): Evidence for the involvement of tuberoinfundibular cholinergic and dopaminergic systemsin neuroendocrine regulation. Endocrinology 101: 613-622.
11. Nagasawa H, Yanai R, Kikuyama S (1974) Irreversible inhibition of pituitary prolactin and growth hormone secretion and of mammary gland development in mice by monosodium glutamate administered neonatally. Acta Endocr 75: 249-259.
12. Redding TW, Schally AV, Arimura A, Wakabayashi I (1971) Effect of monosodium glutamate on some endocrine functions. Neuroendocrinology 8: 245-255.
13. Bloch B, Ling N, Benoit R, Wehrenberg WB, Guillemin R (1984) Specific depletion of immunoreactive growth hormone-releasing factor by monosodium glutamate in rat median eminence. Nature 307: 272-273.
14. Unterman TG, Vasquez RM, Slas AJ, Martyn PA, Phillips LS (1985) Nutritional and somatomedin. VIII. Usefulness of somatomedin-C in nutritional assessment. Am J Med 78: 228-234.
15. Hochberg Z, Hertz P, Colin V, Shalom S, Yeshurun D, Youdim MBH, Amit T (1992) The distal axis of growth hormone (GH) in nutritional disorders: GH-binding protein, insulin-like growth factor-I (IGF-I), and IGF-I receptors in obesity and anorexia nervosa. Metabolism 41: 106-112.
16. Inoue F (1985) Intestinal disaccharidases in monosodium L-glutamate treated obese mice. I. Developmental alteration in intestinal brush border enzyme activities. J Kyoto Pref Univ Med 94: 7-16.
17. Poon TY-K, Cameron DP (1978) Measurement of oxygen consumption and locomotor activity in monosodium glutamate-induced obesity. Am J Physiol 234: E532-534.
18. Yoshioka K, Yoshida T, Kondo M (1991) Reduced brown adipose tissue thermogenesis and metabolic rate in pre-obese mice treated with monosodium-L-glutamate. Endocrinol Japon 38: 75-79.
19. Cameron DP, Cutbush L, Opat F (1978) Effects of monosodium glutamate-induced obesity in mice on carbohydrate metabolism in insulin secretion. Clin Exp Pharmacol Physiol 5: 41-51.
20. Furukawa N (1981) Carbohydrate metabolism in monosodium L-glutamate-treated obese mice. I. Gluconeogenesis and glycolysis in liver. J Kyoto Pre f Univ Med 90: 339-350 (In Japanese).
21. Inoue S, Mullen YS, Bray GA (1983) Hyperinsulinemia in rats with hypothalamic obesity: effects of autonomic drugs and glucose. Am J Physiol 245: R372-378.